Evidence map›Paper›PMID 35455612›Full record

ArticleChildren (Basel, Switzerland)2022

Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients.

Matthew L Stoll, Kimberly DeQuattro, Zhixiu Li, Henna Sawhney, Pamela F Weiss, Peter A Nigrovic, Tracey B Wright, Kenneth Schikler, Barbara Edelheit, Casey D Morrow and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 3 countries.

Matthew L StollDepartment of Pediatrics, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USA.ORCID 0000-0002-6225-3690
Kimberly DeQuattroDepartment of Medicine, Division of Rheumatology, University of Pennsylvania, Pennsylvania, PA 19104, USA.
Zhixiu LiCentre for Genomics and Personalized Health, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
Henna SawhneyDivision of Global Migration and Quarantine, Center for Disease Control, Washington, DC 30329, USA.ORCID 0000-0003-2898-5318
Pamela F WeissDepartment of Pediatrics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, PA 19104, USA.
Peter A NigrovicDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA.
Tracey B WrightDepartment of Pediatrics, University of Texas at Southwestern, Dallas, TX 75390, USA.
Kenneth SchiklerDepartment of Pediatrics, University of Louisville, Louisville, KY 40292, USA.
Barbara EdelheitDepartment of Pediatrics, Connecticut Children's Medical Center, Hartford, CT 06106, USA.
Casey D MorrowDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
John D ReveilleDepartment of Internal Medicine, University of Texas at Houston, Houston, TX 77030, USA.
Matthew A BrownGenomics England, London EC1M 6BQ, UK.
Lianne S GenslerDepartment of Medicine, Division of Rheumatology, University of California at San Francisco, San Francisco, CA 94143, USA.
University of Alabama at Birmingham · USBrigham and Women's Hospital · USChildren's Hospital of Philadelphia · USConnecticut Children's Medical Center · USKing's College London · GBQueensland University of Technology · AUThe University of Texas Southwestern Medical Center · USUniversity of California, San Francisco · USUniversity of Louisville · USUniversity of Pennsylvania · US

Funding

Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
UAB Multidisciplinary Clinical Research CenterP60AR064172 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRIDGES, S LOUIS · 2013 to 2018
$4.5M
Bridging the gap between GWAS and mechanism in JIAR01AR073201 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic · 2019 to 2026
$3.2M
NIAMS NIH HHS P30 AR070253NIH HHS 2P30AR070253NIH HHS P01-052915-06NIH HHS P60 AR064172NIH HHS R01AR073201Spondylitis Association of America N/A
6 · The paper itself

Abstract

Multiple studies have shown the microbiota to be abnormal in patients with spondyloarthritis (SpA). The purpose of this study was to explore the genetic contributions of these microbiota abnormalities. We analyzed the impact of HLA-B27 on the microbiota of children at risk for SpA and compared the microbiota of HLA-B27+ pediatric offspring of ankylosing spondylitis (AS) patients with that of HLA-B27+ children with SpA. Human DNA was obtained from the offspring for determination of HLA-B27 status and polygenic risk score (PRS). Fecal specimens were collected from both groups for sequencing of the V4 region of the 16S ribosomal RNA gene. Among the offspring of AS patients, there was slight clustering by HLA-B27 status. After adjusting for multiple comparisons, five operational taxonomic units (OTUs) representing three unique taxa distinguished the HLA-B27+ from negative children:

Indexed as

HLA-B27microbiotaspondyloarthritis

Identifiers

PMID35455612
PMCPMC9030797
OpenAlexW4223958376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.